Ori Braitbard

2006- 2010   Post-Doctoral fellow,
Dept. of Cell and Developmental Biology, Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem, Israel.
Supervisor: Prof. Jacob Hochman

 Research interests: 
1. Developing novel approaches toward reversal of multi-drug resistance in cancer.
2. Vaccination against breast cancer.

2001- 2005    Ph.D.,
Dept. of Biological Chemistry, Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem, Israel.
 Supervisors: Prof. Wilfred D. Stein and Prof. Deborah Rund.

 Research Title: Characterization of proteins that are involved in resistance to chemotherapy in different kinds of leukemia

1999-2000  M.Sc., Dept. of Biological Chemistry, Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem, Israel. Supervisor: Prof. Wilfred D. Stein

Thesis Title: Methods to estimate the amount and cost of production of P-   glycoprotein from different sources of membranes.

1996-99  B.Sc.
Degree in Biology, Faculty of Life Sciences, Bar Ilan University, Ramat Gan, Israel.

1992-95 Senior Teacher
Degree in Bible and Gmara, The E.M. Liphshitz     Religious Teachers College, Kiryat Shmona (the northern branch), Israel.

Peer-Reviewed Papers in Refereed Journals

1. Ori Braitbard, Janette Bishara-Shieban, Hava Glickstein, Miriam Kott-Gutkowski Umberto Pace, Deborah G. Rund and Wilfred D. Stein .
   An ELISA-based procedure for assaying proteins in digests of human lymphocytes and cell lines, using specifically chosen peptides
   and appropriate antibodies.
2.   Impact Factor: 1.73  Cited by 3  Rank: Q2.
   Ori Braitbard, Hava Glickstein, Janette Bishara-Shieban, Umberto Pace, Wilfred D. Stein .

3. Competition between bound and free peptides in an ELISA-based procedure that assays peptides derived from protein digests
   Proteome Science  2006, 4:12 , 1-12

4.  Impact Factor: 1.73   Cited by 9  Rank: Q2.

   3. Uziel Sandler, Orly Devary, Ori Braitbard, Joel Ohana, Gideon Kass, Ariel M. Rubinstein, Zeev Y. Friedman and Yoram Devary

        NEROFE™ - A novel human hormone-peptide with anti-cancer activity

   Journal of Experimental Therapeutics and

 Kamin Grant - The Office of the Chief Scientist of the Ministry of Industry.

Highly Active, Selective, Stable, and Accessible Anti-Cancer Complexes based on the Bio-Friendly Titanium(IV ) With Prof. Edit Tshuva ($200,000), 2014-2015.

INTERNATIONAL UNION AGAINST CANCER Fellowship - ICRETT 1009/2004

  Host : Dr. Susan Bates - Molecular Therapeutics Section, Nationa Cancer Institute,National Institutes of Health - Bethesda, USA.

Other Relevant Academic and Professional Activities

2010—present
Research Associate –The Institute of Chemistry and the Dept. of Cell and Developmental Biology, Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem, Israel.

Research interests:

1.Biological Applications of Ti(IV) Complexes (with Prof. Edit Y. Tshuva - Institute of Chemistry) .
2. Developing novel approaches toward reversal of multi-drug resistance in cancer.
3. Vaccination against breast cancer (with Jacob Hochman- Dept. of Cell and Developmental Biology).

2006- 2020
Senior Scientist -  Immune System Key ltd.

1999-2006
Researcher - MDR Tests ltd.